Microvision earnings release, May 13, 2026

Microvision, Inc. (MVIS) · Form 8-K, Item 2.02 · Filed · SEC filing

Exhibit

99.1

MicroVision

Announces First Quarter 2026 Results

REDMOND,

WA / ACCESSWIRE / May 13, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its first quarter 2026 results.

Key

Business and Operational Highlights

“We feel very good about our accelerating progress throughout the first quarter, establishing a strong foundation and boldly executing on our strategy to transform the lidar industry,” said Glen DeVos, MicroVision’s Chief Executive Officer. “Following the

Q1 asset acquisitions from Luminar and Scantinel, we’ve successfully incorporated the technologies and products, integrated the teams, and streamlined operations. Our broad product portfolio, ready-to-ship sensor inventories, and diversified product roadmap have allowed us to stabilize and strengthen existing commercial relationships while building new opportunities and partnerships.”

“We’ve taken on the challenge of redefining lidar, and it is exciting to see the future taking shape,” concluded DeVos.

Key

Financial Highlights for Q1 2026

Upcoming

Investor Events

Management will participate in the Deutsche Bank Securities Global Autos, Mobility & Robotics Conference, May 19 – 20, 2026 in New York

City.

Conference

Call and Webcast: Q1 2026 Results

MicroVision will host a conference call and webcast, consisting of prepared remarks by management and a question-and-answer session at 1:30 PM PT/4:30

PM ET on Wednesday, May 13, 2026 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 13, 2026.

The live webcast can be accessed on the Company’s Investor Relations website under the Events tab

HERE. The webcast will be archived on the website for future viewing.

About

MicroVision

MicroVision is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.

For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

MicroVision,

MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP information

To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; severance expense; and impairment charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.

Adjusted

EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.

The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The

Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted

EBITDA.

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is... (truncated)ding investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking

Statements

Financial statements

Income Statement

Three months ended March 31, — (In thousands, except per share data)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Revenue935589
Cost of revenue572550
Gross profit36339
Research and development expense14,4457,403
Sales, marketing, general and administrative expense9,5116,676
Impairment loss on operating lease right-of-use assets9
Gain on disposal of fixed assets-108
Total operating expenses23,85714,079
Loss from operations-23,494-14,040
Interest expense-2,753-12,903
Unrealized gain on derivative liability3,380842
Unrealized gain on warrant liability6041,761
Realized loss on debt extinguishment-3,083-4,654
Bargain purchase gain147
Other income87288
Net loss before taxes-25,112-28,706
Income tax expense-182-73
Net loss-25,294-28,779
Net loss per share - basic and diluted-0.08-0.12
Weighted-average shares outstanding - basic and diluted308,650235,933

Income Statement

Three months ended March 31, — (In thousands) (in thousands)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Reconciliation of Non-GAAP Gross Profit:Gross profit36339
Reconciliation of Non-GAAP Gross Profit:Inventory related write-downs27
Reconciliation of Non-GAAP Gross Profit:Amortization of acquired intangibles217
Reconciliation of Non-GAAP Gross Profit:Adjusted Gross Profit390256
Reconciliation of Non-GAAP Loss:GAAP Net loss-25,294-28,779
Reconciliation of Non-GAAP Loss:Interest expense, net2,66612,615
Reconciliation of Non-GAAP Loss:Provision for income taxes18273
Reconciliation of Non-GAAP Loss:Depreciation and amortization2,3681,408
Reconciliation of Non-GAAP Loss:Unrealized gain on derivative liability-3,380-842
Reconciliation of Non-GAAP Loss:Unrealized gain on warrant liability-604-1,761
Reconciliation of Non-GAAP Loss:Loss on debt extinguishment3,0834,654
Reconciliation of Non-GAAP Loss:Gain on disposal of fixed assets-108
Reconciliation of Non-GAAP Loss:Impairment of operating lease right-of-use assets9
Reconciliation of Non-GAAP Loss:Share-based compensation expense9831,921
Reconciliation of Non-GAAP Loss:Inventory related write-downs27
Reconciliation of Non-GAAP Loss:Acquisition-related costs1,727
Reconciliation of Non-GAAP Loss:Restructuring charges1,139
Reconciliation of Non-GAAP Loss:Adjusted EBITDA-17,202-10,711

Balance Sheet

December 31, — (In thousands) (in thousands)

March 31, – 2026December 31, – 2025
Current assetsCash and cash equivalents46,12032,363
Current assetsInvestment securities, available-for-sale42,471
Current assetsRestricted cash, current485497
Current assetsAccounts receivable, net of allowances73247
Current assetsInventory4,028745
Current assetsOther current assets2,8584,989
Current assetsTotal current assets54,22381,112
Current assetsProperty and equipment, net17,3004,280
Current assetsOperating lease right-of-use assets17,92914,075
Current assetsRestricted cash, net of current portion1,1891,204
Current assetsIntangible assets, net13,66232
Current assetsGoodwill3,677
Current assetsOther assets2,2242,416
Current assetsTotal assets110,204103,119
Current liabilitiesAccounts payable4,5371,628
Current liabilitiesAccrued liabilities7,5425,426
Current liabilitiesDeferred revenue411
Current liabilitiesDerivative liability2,035
Current liabilitiesNotes payable32,14119,212
Current liabilitiesOperating lease liabilities, current4,9853,481
Current liabilitiesFinance lease liabilities, current1314
Current liabilitiesOther current liabilities99388
Current liabilitiesTotal current liabilities51,76330,149
Current liabilitiesWarrant liability1,2711,875
Current liabilitiesOperating lease liabilities, net of current portion16,25914,034
Current liabilitiesFinance lease liabilities, net of current portion2127
Current liabilitiesOther long-term liabilities1,3471,486
Current liabilitiesTotal liabilities70,66147,571
Shareholders’ equityCommon stock at par value322306
Shareholders’ equityAdditional paid-in capital1,021,2181,011,835
Shareholders’ equityAccumulated other comprehensive income559669
Shareholders’ equityAccumulated deficit-982,556-957,262
Shareholders’ equityTotal shareholders’ equity39,54355,548
Shareholders’ equityTotal liabilities and shareholders’ equity110,204103,119

Cash Flow

Three months ended March 31, — (In thousands) (in thousands)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Cash flows from operating activitiesNet loss-25,294-28,779
Adjustments to reconcile net loss to net cash used in operations:Depreciation and amortization2,3681,408
Adjustments to reconcile net loss to net cash used in operations:Unrealized gain on derivative liability-3,380-842
Adjustments to reconcile net loss to net cash used in operations:Unrealized gain on warrant liability-604-1,761
Adjustments to reconcile net loss to net cash used in operations:Loss on debt extinguishment3,0834,654
Adjustments to reconcile net loss to net cash used in operations:Bargain purchase gain-147
Adjustments to reconcile net loss to net cash used in operations:Gain on disposal of fixed assets-108
Adjustments to reconcile net loss to net cash used in operations:Impairment of operating lease right-of-use assets9
Adjustments to reconcile net loss to net cash used in operations:Inventory write-downs27
Full release

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor

Relations Contact

Jeff

Christensen

Darrow

Associates Investor Relations

MVIS@darrowir.com

Media

Contact

Marketing@MicroVision.com

Source:

MicroVision, Inc.

MicroVision,

Inc.

Consolidated

Balance Sheets

(In thousands)

MicroVision,

Inc.

Consolidated

Statement of Operations

(In thousands, except per share data)

MicroVision,

Inc.

Consolidated

Statements of Cash Flows

(In thousands)

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of March 31, 2026 and 2025:

MicroVision,

Inc.

Reconciliation of GAAP to Non-GAAP Measures

(In thousands)

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Microvision earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.